Advertisement

Topics

Jennewein Biotechnologie GmbH Company Profile

13:47 EST 24th November 2017 | BioPortfolio


News Articles [167 Associated News Articles listed on BioPortfolio]

Rentschler Biotechnologie GmbH transforms into European corporation

Rentschler Biotechnologie GmbH announced that the Company has successfully transitioned into a European corporation (SE) with entry into the German commercial register on October 1, 2017. The Company ...

MTZ-BIOPRO Schülerpreis 2017

Die ersten Auszeichnungen der gemeinnützigen MTZ®stiftung und der Landesagentur BIOPRO Baden-Württemberg GmbH an 26 Biotechnologie-Gymnasien liegen zehn Jahre zurück. Seit der MTZ®-BIOPRO Schüle...

Rentschler Biotechnologie GmbH & Co. Announces Transition Into A European Corporation Called

  Life Sciences Jobs   ...

Rentschler Biotechnologie: Klaus B. Schoepe

In this episode of PharmaTelevision News Review, Fintan Walton talks to Klaus B. Schoepe, Senior Vice President Client Relations at Rentschler Biotechnologie

Global and Asia Human Milk Oligosaccharides HMO Market Status and Future Forecast 20132023 [Report Updated: 17102017] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

Global and China Human Milk Oligosaccharides HMO Market Research by Company, Type Application 20132025 [Report Updated: 28102017] Prices from USD $2000

SummaryMarket Segment as follows:By Type Neutral Acidic OtherBy Application Infant formula Functional food beverages Food supplements OthersBy Company Inbiose Elicityl SA ...

Bioprozesstechnik – Schlüsseldisziplin der Biotechnologie

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

PubMed Articles [15 Associated PubMed Articles listed on BioPortfolio]

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.

To evaluate safety (primary objective) and efficacy of increasing doses (400 U up to 800 U) of incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals GmbH) for patients with limb spasticity.

Biomechanical Characterization of Subclinical Keratoconus Without Topographic or Tomographic Abnormalities.

To present a case series of patients with subclinical keratoconus with normal topometric (anterior curvature) and tomographic findings in one eye who showed abnormalities detected by Corvis ST (Oculus...

Pulled-out locking screw re-screwed spontaneously in anterior cervical decompression and fusion with the zero-profile implant system: A case report.

The zero-profile, standalone device (Zero-P, Synthes GmbH, Switzerland) has been reported to be an effective and safe treatment method with similar clinical outcomes compared with plate. Instrumental ...

Cyclic and Torsional Fatigue Resistance of Reciprocating Single Files Manufactured by Different Nickel-titanium Alloys.

The aim of this study was to evaluate the cyclic and torsional fatigue resistance of the following reciprocating single-file systems: ProDesign R 25.06 (Easy Equipamentos Odontológicos, Belo Horizont...

Reliability of a Skin Diagnostic Device in Assessing Hydration and Erythema.

To examine the reliability of a skin diagnostic device, the SD202 (Courage+Khazaka GmBH, Cologne, Germany), in assessing hydration and erythema of periwound skin and pressure injury-prone areas.

Clinical Trials [39 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Telemedical Examination of a Three-Component Oculomotor Testing Battery

The study investigates the feasibility and safety of the telemedical implementation of three diagnostic oculomotor tests using a video-oculography device and an extended teleconferencing s...

Influence of Non-invasive Neurostimulation (Transcutaneous Vagus Nerve Stimulation) on 1. the Noradrenergic Release in the Brain and 2. a Neuropsychological Memory Task

The goal of this study is to investigate the influence of transcutaneous vagus nerve stimulation 1. on the noradrenergic system in the brain and 2. on memory, in healthy volunteers. ...

Companies [537 Associated Companies listed on BioPortfolio]

Jennewein Biotechnologie GmbH

BIOTECHNOLOGIE KEMPE GMBH

BIOTECHNOLOGIE KEMPE GMBH has been located in Berlin for more than twenty years (since 2004 on the outskirts of the city). We focus on development and construction of measuring and control equipment f...

Cephalon GmbH

Für die Betreuung der Märkte in Deutschland, Österreich und der Schweiz wurde 1997 in München die Cephalon GmbH gegründet. Im Jahr 2002 erfolgte der Umzug nach Martinsried bei München, einem der...

Centre québécois d'innovation en biotechnologie

Le Centre québécois d'innovation en biotechnologie (CQIB), un organisme privé sans but lucratif fondé en 1995, est un incubateur d'entreprises spécialisé en biotechnologie. Accompagner, Innover,...

AnalytiCon AG Biotechnologie-Pharmazie

AnalytiCon AG Biotechnologie Pharmazie provides quality control, research and development.

More Information about "Jennewein Biotechnologie GmbH" on BioPortfolio

We have published hundreds of Jennewein Biotechnologie GmbH news stories on BioPortfolio along with dozens of Jennewein Biotechnologie GmbH Clinical Trials and PubMed Articles about Jennewein Biotechnologie GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Jennewein Biotechnologie GmbH Companies in our database. You can also find out about relevant Jennewein Biotechnologie GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record